Drug Shortage Report for RIVA-OLMESARTAN
| Report ID | 55210 |
| Drug Identification Number | 02471361 |
| Brand name | RIVA-OLMESARTAN |
| Common or Proper name | Riva-Olmesartan 40mg |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | OLMESARTAN MEDOXOMIL |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 / 100 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2018-07-10 |
| Actual start date | 2018-07-10 |
| Estimated end date | Unknown |
| Actual end date | 2019-04-17 |
| Shortage status | Resolved |
| Updated date | 2019-04-18 |
| Company comments | Discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-04-18 | English | Compare |
| v5 | 2019-04-17 | French | Compare |
| v4 | 2019-04-17 | English | Compare |
| v3 | 2018-07-11 | English | Compare |
| v2 | 2018-07-10 | French | Compare |
| v1 | 2018-07-10 | English | Compare |
Showing 1 to 6 of 6